Photo from academic.microsoft.com
11 Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study Carolyn J. Crandall, MD, MS, Kathleen M. Hovey, MS,… Click to show full abstract
11 Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study Carolyn J. Crandall, MD, MS, Kathleen M. Hovey, MS, Christopher A. Andrews, PhD, Rowan T. Chlebowski, MD, PhD, Marcia L. Stefanick, PhD, Dorothy S. Lane, MD, MPH, Jan Shifren, MD, Chu Chen, PhD, Andrew M. Kaunitz, MD, Jane A. Cauley, DrPH, and JoAnn E. Manson, MD, DrPH The risks of cardiovascular disease and cancer were not elevated among postmenopausal participants in the Women’s Health Initiative Observational Study using vaginal estrogens, providing reassurance about the safety of treatment. Menopause
Journal Title: Menopause
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!